AUPH FY 2010 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-15.6% YoY

Gross Profit

$3M98.5% margin

Operating Income

-$5M-147.5% margin

Net Income

-$4M-107.0% margin

EPS (Diluted)

$-1.44

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10M

Total Liabilities

$4M

Stockholders' Equity

$6M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-15.6%
Gross Profit	$3M	$3M	-3.1%
Operating Income	-$5M	-$10M	+49.8%
Net Income	-$4M	-$8M	+51.8%